Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Welsh

Showing results (291-300 of 329) with videos related to

Pageof 33
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 9, 2021
Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort studyJana J Anderson, Frederick K Ho, Claire L Niedzwiedz, et al.
European Journal of Heart Failure|January 22, 2022
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HFKirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
Heart (British Cardiac Society)|January 13, 2021
Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trialAnnette Marie Maznyczka, Peter McCartney, Patrycja Duklas, et al.
Journal of the American Heart Association|January 29, 2020
Effects of Intracoronary Alteplase on Microvascular Function in Acute Myocardial InfarctionAnnette M Maznyczka, Peter J McCartney, Keith G Oldroyd, et al.
Circulation|April 11, 2023
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HFSu Ern Yeoh, Kieran F Docherty, Ross T Campbell, et al.
Open Heart|October 10, 2025
<i><b>PCSK9</b></i> <b>genetic variants, carotid atherosclerosis and vascular remodelling</b>Daniela Coggi, Joey Ward, Chiara Macchi, et al.
JACC. Heart Failure|March 15, 2025
Interleukin-6 in Heart Failure With Reduced Ejection Fraction and the Effect of Dapagliflozin: An Exploratory Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure TrialKieran F Docherty, Kirsty McDowell, Paul Welsh, et al.
European Journal of Heart Failure|May 14, 2024
Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HFJames P Curtain, Atefeh Talebi, Alasdair McIntosh, et al.
Circulation|August 16, 2022
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HFKieran F Docherty, Paul Welsh, Subodh Verma, et al.
Cell Genomics|May 1, 2024
Blood-based epigenome-wide analyses of chronic low-grade inflammation across diverse population cohortsRobert F Hillary, Hong Kiat Ng, Daniel L McCartney, et al.
Pageof 33

Showing results (291-300 of 329) with videos related to

Sort By:
Pageof 33
Journal of Thrombosis and Haemostasis : JTH|July 9, 2021
Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort studyJana J Anderson, Frederick K Ho, Claire L Niedzwiedz, et al.
European Journal of Heart Failure|January 22, 2022
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HFKirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
Heart (British Cardiac Society)|January 13, 2021
Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trialAnnette Marie Maznyczka, Peter McCartney, Patrycja Duklas, et al.
Journal of the American Heart Association|January 29, 2020
Effects of Intracoronary Alteplase on Microvascular Function in Acute Myocardial InfarctionAnnette M Maznyczka, Peter J McCartney, Keith G Oldroyd, et al.
Circulation|April 11, 2023
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HFSu Ern Yeoh, Kieran F Docherty, Ross T Campbell, et al.
Open Heart|October 10, 2025
<i><b>PCSK9</b></i> <b>genetic variants, carotid atherosclerosis and vascular remodelling</b>Daniela Coggi, Joey Ward, Chiara Macchi, et al.
JACC. Heart Failure|March 15, 2025
Interleukin-6 in Heart Failure With Reduced Ejection Fraction and the Effect of Dapagliflozin: An Exploratory Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure TrialKieran F Docherty, Kirsty McDowell, Paul Welsh, et al.
European Journal of Heart Failure|May 14, 2024
Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HFJames P Curtain, Atefeh Talebi, Alasdair McIntosh, et al.
Circulation|August 16, 2022
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HFKieran F Docherty, Paul Welsh, Subodh Verma, et al.
Cell Genomics|May 1, 2024
Blood-based epigenome-wide analyses of chronic low-grade inflammation across diverse population cohortsRobert F Hillary, Hong Kiat Ng, Daniel L McCartney, et al.
Pageof 33